Evidence map›Paper›PMID 27610753›Full record

ReviewPharmaceutical patent analyst2016

Fluorine-18 patents (2009-2015). Part 2: new radiochemistry.

Andrew V Mossine, Stephen Thompson, Allen F Brooks, Alexandra R Sowa, Jason M Miller, Peter Jh Scott

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutical patent analyst, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Optimization of Precursor Synthesis Conditions of (2S,4S)4-[Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrew V MossineDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Stephen ThompsonDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Allen F BrooksDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
Alexandra R SowaDepartment of Medicinal Chemistry, University of Michigan, 428 Church St., Ann Arbor, MI 48109, USA.
Jason M MillerDepartment of Medicinal Chemistry, University of Michigan, 428 Church St., Ann Arbor, MI 48109, USA.
Peter Jh ScottDepartment of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA.
University of Michigan–Ann Arbor · USMichigan Medicine · US

Funding

Training Future Imaging Scientists for BiomedicineT32EB005172 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FOWLKES, JEFFREY B · 2008 to 2012
$1.1M
NIBIB NIH HHS T32 EB005172
6 · The paper itself

Abstract

Fluorine-18 ((18)F) is one of the most common positron-emitting radionuclides used in the synthesis of positron emission tomography radiotracers due to its ready availability, convenient half-life and outstanding imaging properties. In Part 1 of this review, we presented the first analysis of patents issued for novel radiotracers labeled with fluorine-18. In Part 2, we follow-up with a focus on patents issued for new radiochemistry methodology using fluorine-18 issued between January 2009 and December 2015.

Indexed as

Fluorine RadioisotopesAnimalsHumansPatents as TopicPositron-Emission TomographyRadiochemistryFluorine Radioisotopes18Ffluorine-18PET radiotracerspositron emission tomographyradiochemistry

Identifiers

PMID27610753
PMCPMC5138992
OpenAlexW2508337865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.